Peloton Wealth Strategists’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.49M | Buy |
17,180
+3,750
| +28% | +$359K | 0.6% | 55 |
|
|
2025
Q4 | $1.29M | Buy |
13,430
+900
| +7% | +$87.4K | 0.5% | 62 |
|
|
2025
Q3 | $1.19M | Sell |
12,530
-100
| -0.8% | -$9.19K | 0.47% | 66 |
|
|
2025
Q2 | $1.1M | Hold |
12,630
| – | – | 0.44% | 64 |
|
|
2025
Q1 | $1.14M | Buy |
12,630
+1,810
| +17% | +$162K | 0.47% | 65 |
|
|
2024
Q4 | $864K | Buy |
10,820
+200
| +2% | +$17.3K | 0.35% | 65 |
|
|
2024
Q3 | $956K | Sell |
10,620
-1,315
| -11% | -$111K | 0.38% | 68 |
|
|
2024
Q2 | $939K | Buy |
11,935
+75
| +0.6% | +$6.15K | 0.39% | 64 |
|
|
2024
Q1 | $1.03M | Sell |
11,860
-5,400
| -31% | -$461K | 0.42% | 65 |
|
|
2023
Q4 | $1.42M | Sell |
17,260
-2,190
| -11% | -$167K | 0.62% | 57 |
|
|
2023
Q3 | $1.52M | Sell |
19,450
-13,450
| -41% | -$1.13M | 0.7% | 54 |
|
|
2023
Q2 | $2.9M | Hold |
32,900
| – | – | 1.28% | 34 |
|
|
2023
Q1 | $2.65M | Buy |
32,900
+600
| +2% | +$48.9K | 1.21% | 35 |
|
|
2022
Q4 | $2.51M | Buy |
32,300
+400
| +1% | +$32.4K | 1.21% | 35 |
|
|
2022
Q3 | $2.58M | Sell |
31,900
-150
| -0.5% | -$13.5K | 1.34% | 31 |
|
|
2022
Q2 | $2.88M | Sell |
32,050
-2,150
| -6% | -$218K | 1.4% | 27 |
|
|
2022
Q1 | $3.79M | Sell |
34,200
-2,654
| -7% | -$280K | 1.59% | 26 |
|
|
2021
Q4 | $3.81M | Sell |
36,854
-1,565
| -4% | -$181K | 1.53% | 27 |
|
|
2021
Q3 | $4.82M | Sell |
38,419
-700
| -2% | -$90.6K | 1.97% | 19 |
|
|
2021
Q2 | $4.86M | Buy |
39,119
+1,384
| +4% | +$174K | 2% | 18 |
|
|
2021
Q1 | $4.46M | Sell |
37,735
-515
| -1% | -$60.4K | 2.09% | 17 |
|
|
2020
Q4 | $4.48M | Buy |
38,250
+250
| +0.7% | +$27.5K | 2.22% | 19 |
|
|
2020
Q3 | $3.95M | Buy |
38,000
+900
| +2% | +$90.4K | 2.21% | 15 |
|
|
2020
Q2 | $3.4M | Buy |
37,100
+2,500
| +7% | +$240K | 2.14% | 17 |
|
|
2020
Q1 | $3.12M | Sell |
34,600
-300
| -0.9% | -$31.9K | 2.54% | 8 |
|
|
2019
Q4 | $3.96M | Sell |
34,900
-2,500
| -7% | -$274K | 2.4% | 9 |
|
|
2019
Q3 | $4.06M | Hold |
37,400
| – | – | 2.6% | 10 |
|
|
2019
Q2 | $3.64M | Sell |
37,400
-1,600
| -4% | -$146K | 2.44% | 13 |
|
|
2019
Q1 | $3.55M | Buy |
39,000
+600
| +2% | +$53.7K | 2.46% | 12 |
|
|
2018
Q4 | $3.49M | Sell |
38,400
-821
| -2% | -$76.7K | 2.84% | 8 |
|
|
2018
Q3 | $3.86M | Buy |
39,221
+600
| +2% | +$55.5K | 2.65% | 8 |
|
|
2018
Q2 | $3.31M | Buy |
38,621
+5,450
| +16% | +$455K | 2.39% | 10 |
|
|
2018
Q1 | $2.66M | Buy |
33,171
+20,521
| +162% | +$1.69M | 2% | 23 |
|
|
2017
Q4 | $1.02M | Buy |
+12,650
| New | +$1.01M | 0.76% | 52 |
|
Other funds holding MDT
VCM
VPM
Peloton Wealth Strategists's MDT Position: Q1 2026 in Review
Peloton Wealth Strategists increased its Medtronic (MDT) stake by 28% in Q1 2026, buying an estimated $359K and bringing the position to 17,180 shares worth $1.49M. The position accounts for 0.6% of the portfolio, ranked #55.
Peloton Wealth Strategists first reported a position in MDT in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.86M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Peloton Wealth Strategists held 17,180 shares of Medtronic worth $1.49M as of Q1 2026.
- Peloton Wealth Strategists bought 3,750 Medtronic shares in Q1 2026, an estimated $359K.
- Medtronic made up 0.6% of Peloton Wealth Strategists's portfolio in Q1 2026, its #55 holding.
- Peloton Wealth Strategists first reported a position in Medtronic in Q4 2017 and has held it in 34 quarters since.
- Peloton Wealth Strategists's Medtronic position peaked at $4.86M in Q2 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Peloton Wealth Strategists's 13F filing for Q1 2026, filed 14 May 2026.